Center-Authored Papers

Filters: Author is Moinpour, Carol M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zhong X, Lim EA, Hershman DL, Moinpour CM, Unger J, Lee SM, Zhong X, Lim EA, Hershman DL, Moinpour CM et al..  2016.  ReCAP: Identifying Severe Adverse Event Clusters Using the National Cancer Institute's Common Terminology Criteria for Adverse Events.. Journal of oncology practice / American Society of Clinical Oncology. Abstract
Zeliadt SB, Penson DF, Moinpour CM, Blough DK, Fedorenko CR, Hall IJ, Smith JL, Ekwueme DU, Thompson IM, Keane TE et al..  2011.  Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer.. BJU international. 108(6):851-6. Abstract
Zeliadt SB, Moinpour CM, Blough DK, Penson DF, Hall IJ, Smith JL, Ekwueme DU, Thompson IM, Keane TE, Ramsey SD.  2010.  Preliminary treatment considerations among men with newly diagnosed prostate cancer.. The American journal of managed care. 16(5):e121-30. Abstract
V
Victorson DE, Brucker PS, Bode RK, Eton DT, Talcott JA, Clark JA, Knight SJ, Litwin MS, Moinpour CM, Reeve BB et al..  2013.  Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance.. Urologic oncology. Abstract
Van Poznak CH, Darke A, Moinpour CM, Bagramian RA, Schubert MM, Gralow JR, Wade JL, Unger JM.  2016.  Dental health status and patient-reported outcomes at baseline in patients participating in the osteonecrosis of the jaw registry study, SWOG S0702.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. Abstract
U
Unger JM, Hershman DL, Albain KS, Moinpour CM, Petersen JA, Burg K, Crowley JJ.  2013.  Patient income level and cancer clinical trial participation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(5):536-42. Abstract
S
Schott AF, Barlow WE, Van Poznak CH, Hayes DF, Moinpour CM, Lew DL, Dy PA, Keller ET, Keller JM, Hortobagyi GN.  2016.  Phase II studies of two different schedules of dasatinib in ***bone metastasis predominant metastatic breast cancer: SWOG S0622.. Breast cancer research and treatment. Abstract
R
Rim SH, Hall IJ, Fairweather ME, Fedorenko CR, Ekwueme DU, Smith JL, Thompson IM, Keane TE, Penson DF, Moinpour CM et al..  2011.  Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population.. International journal of general medicine. 4:481-6. Abstract
Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD et al..  2013.  ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. Abstract
Ramsey SD, Zeliadt SB, Blough DK, Moinpour CM, Hall IJ, Smith JL, Ekwueme DU, Fedorenko CR, Fairweather ME, Koepl LM et al..  2013.  Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences.. The journal of sexual medicine. 10(12):3135-43. Abstract
Ramsey SD, Zeliadt SB, Fedorenko CR, Blough DK, Moinpour CM, Hall IJ, Smith JL, Ekwueme DU, Fairweather ME, Thompson IM et al..  2011.  Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions.. World journal of urology. 29(1):3-9. Abstract
Q
Quinn DI, Tangen CM, Hussain M, Lara PN, Goldkorn A, Moinpour CM, Garzotto MG, Mack PC, Carducci MA, Monk PJ et al..  2013.  Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial.. The lancet oncology. 14(9):893-900. Abstract
M
Moinpour CM, Unger JM, Ganz PA, Kornblith AB, Gaynor ER, Bowers MA, Gatti GS, Kaminski MS, Erba HP, Wang T et al..  2016.  Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208.. Journal of cancer survivorship : research and practice. Abstract
Moinpour CM, Donaldson GW, Liepa AM, Melemed AS, O'Shaughnessy J, Albain KS.  2012.  Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monothe. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 21(5):765-775. Abstract
Moinpour CM, Vaught NL, Goldman B, Redman MW, Philip PA, Millwood B, Lippman SM, Seay TE, Flynn PJ, O'Reilly EM et al..  2010.  Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(22):3611-6. Abstract
Moinpour CM, Donaldson GW, Davis KM, Potosky AL, Jensen RE, Gralow JR, Back AL, Hwang JJ, Yoon J, Bernard DL et al..  2016.  The challenge of measuring intra-individual change in fatigue during cancer treatment.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. Abstract
Moinpour CM, Donaldson GW, Liepa AM, Melemed AS, O'Shaughnessy J, Albain KS.  2012.  Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monothe. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 21(5):765-75. Abstract
Moinpour CM, Hayden KA, Unger JM, Thompson IM, Redman MW, Canby-Hagino ED, Higgins BA, Sullivan JW, Lemmon D, Breslin S et al..  2008.  Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(1):112-20. Abstract
Moinpour CM, Donaldson GW, Nakamura Y.  2009.  Chemotherapeutic impact on pain and global health-related quality of life in hormone-refractory prostate cancer: Dynamically Modified Outcomes (DYNAMO) analysis of a randomized controlled trial.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 18(2):147-55. Abstract
L
Li C, Zeliadt SB, Hall IJ, Smith JL, Ekwueme DU, Moinpour CM, Penson DF, Thompson IM, Keane TE, Ramsey SD.  2013.  Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. Abstract
Li C, Zeliadt SB, Hall IJ, Smith JL, Ekwueme DU, Moinpour CM, Penson DF, Thompson IM, Keane TE, Ramsey SD.  2012.  Willingness to Pay for Prostate Cancer Treatment among Patients and Their Family Members at 1 Year After Diagnosis.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 15(5):716-23. Abstract
Land SR, Toll BA, Moinpour CM, Mitchell SA, Ostroff JS, Hatsukami DK, Duffy SA, Gritz ER, Rigotti NA, Brandon T et al..  2016.  Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research.. Clinical cancer research : an official journal of the American Association for Cancer Research. 22(8):1907-1913. Abstract
J
Jensen RE, Potosky AL, Moinpour CM, Lobo T, Cella D, Hahn EA, Thissen D, Smith AW, Ahn J, Luta G et al..  2017.  United States Population-Based Estimates of Patient-Reported Outcomes Measurement Information System Symptom and Functional Status Reference Values for Individuals With Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2016714410. Abstract
Jensen RE, Moinpour CM, Potosky AL, Lobo T, Hahn EA, Hays RD, Cella D, Smith AW, Wu X-C, Keegan THM et al..  2016.  Responsiveness of 8 Patient-Reported Outcomes Measurement Information System (PROMIS) measures in a large, community-based cancer study cohort.. Cancer. Abstract
Jensen RE, Potosky AL, Reeve BB, Hahn E, Cella D, Fries J, Smith AW, Keegan THM, Wu X-C, Paddock L et al..  2015.  Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 24(10):2333-44. Abstract